LTR Pharma Limited (AU:LTP) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
LTR Pharma Limited has issued a cleansing notice for the release of over 27 million shares, ensuring compliance with secondary sale requirements. Additionally, the company announced a significant access agreement with Men’s Health Downunder for the distribution of their product SPONTAN. These developments highlight LTR Pharma’s strategic moves to enhance market presence and shareholder value.
For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.